ProfileGDS5678 / 1439878_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 58% 55% 56% 53% 55% 55% 61% 55% 56% 56% 56% 55% 61% 56% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5369558
GSM967853U87-EV human glioblastoma xenograft - Control 23.3803555
GSM967854U87-EV human glioblastoma xenograft - Control 33.4033956
GSM967855U87-EV human glioblastoma xenograft - Control 43.2564453
GSM967856U87-EV human glioblastoma xenograft - Control 53.3398955
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.4585955
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.7581961
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.3736355
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.3756456
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.3944956
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.3986456
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.3506155
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.6675361
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4050456